Blood pressure and glaucoma

British Journal of Ophthalmology

Volumn 93, Issue 10, 2009, Pages 1276-1282

  Costa, V P ^a,b   Arcieri, E S ^a,c   Harris, A ^d  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c FEDERAL UNIVERSITY OF UBERLÂNDIA   (Brazil)

^d INDIANA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD PRESSURE; EYE BLOOD FLOW; GLAUCOMA; HUMAN; HYPERTENSION; INTRAOCULAR PRESSURE; PERFUSION PRESSURE; PRIORITY JOURNAL; REVIEW; RISK FACTOR;

BLOOD PRESSURE; GLAUCOMA; HUMANS; HYPERTENSION; HYPOTENSION; INTRAOCULAR PRESSURE;

EID: 70349976319     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjo.2008.149047     Document Type: Review

References (100)

1. Congdon N, Friedman DS, Lietman T. Important causes of visual impairment in the world today. JAMA 2003;290:2057-2060 (Pubitemid 37430590)
2. Bengtsson B. The prevalence of glaucoma. Br J Ophthalmol 1981;65:46-49
3. Leibowitz HM, Krueger DE, Maunder LR, et al. The Framingham Eye Study monograph. An ophthalmological and epidemiological study of cataract, glaucoma, diabetic retinopathy, macular degeneration, and visual acuity in a general population of 2631 adults. 1973-1975. Surv Ophthalmol 1980;24(Suppl):335-610S.
4. Sommer A, Tielsch JM, Katz J, et al. Relationship between intraocular pressure and primary open angle glaucoma among white and black Americans. The Baltimore Eye Survey. Arch Ophthalmol 1991;109:1090-1095
5. François J, Neetens A. The deterioration of the visual field in glaucoma and the blood pressure. Doc Ophthalmol 1970;28:70-132.
6. Drance SM, Douglas GR, Wijsman K, et al. Response of blood flow to warm and cold in normal and low-tension glaucoma patients. Am J Ophthalmol 1988;105:35-39 (Pubitemid 18021341)
7. McLeod SD, West SK, Quigley HA, et al. A longitudinal study of the relationship between intraocular and blood pressures. Invest Ophthalmol Vis Sci 1990;31:2361-2366
8. Dielemans I, Vingerling JR, Algra D, et al. Primary open-angle glaucoma, intraocular pressure, and systemic blood pressure in the general elderly population. The Rotterdam Study. Ophthalmology 1995;102:54-60.
9. Tielsch JM, Katz J, Sommer A, et al. Hypertension, perfusion pressure, and primary open-angle glaucoma. A population-based assessment. Arch Ophthalmol 1995;113:216-221
10. Leske MC, Connell AM, Wu SY, et al. Risk factors for open-angle glaucoma. The Barbados Eye Study. Arch Ophthalmol 1995;113:918-924
11. Mitchell P, Smith W, Attebo K, et al. Prevalence of open-angle glaucoma in Australia. The Blue Mountains Eye Study. Ophthalmology 1996;103:1661-1669
12. Bonomi L, Marchini G, Marraffa M, et al. Prevalence of glaucoma and intraocular pressure distribution in a defined population. The Egna-Neumarkt Study. Ophthalmology 1998;105:209-215
13. Bonomi L, Marchini G, Marraffa M, et al. Vascular risk factors for primary open angle glaucoma: the Egna-Neumarkt Study. Ophthalmology 2000;107:1287-1293 (Pubitemid 30828492)
14. Leske MC, Wu SY, Nemesure B, et al. Incident open-angle glaucoma and blood pressure. Arch Ophthalmol 2002;120:954-959 (Pubitemid 34755549)
15. Leske MC, Heijl A, Hussein M, et al. Factors for glaucoma progression and the effect of treatment: the Early Manifest Glaucoma Trial. Arch Ophthalmol 2003;121:48-56. (Pubitemid 36401765)
16. Hennis A, Wu SY, Nemesure B, et al. Hypertension, diabetes, and longitudinal changes in intraocular pressure. Ophthalmology 2003;110:908-914 (Pubitemid 36560487)
17. Fuchsjäger-Mayrl G, Wally B, Georgopoulos M, et al. Ocular blood flow and systemic blood pressure in patients with primary open-angle glaucoma and ocular hypertension. Invest Ophthalmol Vis Sci 2004;45:834-839 (Pubitemid 38868379)
18. Mitchell P, Lee AJ, Rochtchina E, et al. Open-angle glaucoma and systemic hypertension: The Blue Mountains Eye Study. J Glaucoma 2004;13:319-326 (Pubitemid 38944201)
19. Varma R, Ying-Lai M, Francis BA, et al. Los Angeles Latino Eye Study Group. Prevalence of open-angle glaucoma and ocular hypertension in Latinos: the Los Angeles Latino Eye Study. Ophthalmology 2004;111:1439-1448
20. Klein BE, Klein R, Knudtson MD. Intraocular pressure and systemic blood pressure: longitudinal perspective: the Beaver Dam Eye Study. Br J Ophthalmol 2005;89:284-287 (Pubitemid 40327608)
21. Suzuki Y, Iwase A, Araie M, et al. Risk factors for open-angle glaucoma in a Japanese population: the Tajimi Study. Ophthalmology 2006;113:1613-1617 (Pubitemid 44292321)
22. Topouzis F, Coleman AL, Harris A, et al. Association of blood pressure status with the optic disk structure in non-glaucoma subjects: the Thessaloniki Eye Study. Am J Ophthalmol 2006;142:60-67 (Pubitemid 43946803)
23. Orzalesi N, Rossetti L, Omboni S, OPTIME Study Group (Osservatorio sulla Patologia glaucomatosa, Indagine Medico Epidemiologica). CONPROSO (Collegio Nazionale dei Professori Ordinari di Scienze Oftalmologiche). Vascular risk factors in glaucoma: the results of a national survey. Graefes Arch Clin Exp Ophthalmol 2007;245:795-802.
24. Hulsman CA, Vingerling JR, Hofman A, et al. Blood pressure, arterial stiffness, and open-angle glaucoma: the Rotterdam study. Arch Ophthalmol 2007;125:805-812 (Pubitemid 46919742)
25. Xu L, Wang H, Wang Y, et al. Intraocular pressure correlated with arterial blood pressure: the Beijing eye study. Am J Ophthalmol 2007;144:461-462 (Pubitemid 47331394)
26. Leske MC, Wu SY, Hennis A, et al. Risk factors for incident open-angle glaucoma: the Barbados Eye Studies. Ophthalmology 2008;115:85-93. (Pubitemid 350309410)
27. Sehi M, Flanagan JG, Zeng L, et al. Relative change in diurnal mean ocular perfusion pressure: a risk factor or the diagnosis of primary open-angle glaucoma. Invest Ophthalmol Vis Sci 2005;46:561-567 (Pubitemid 40270336)
28. Wang S, Xu L, Jonas JB, et al. Retinal vascular abnormalities in adult Chinese in rural and urban Beijing: the Beijing Eye Study. Ophthalmology 2006;113:1752-1757 (Pubitemid 44442439)
29. Xu L, Wang Y, Wang S, et al. High myopia and glaucoma susceptibility: the Beijing Eye Study. Ophthalmology 2007;114:216-220 (Pubitemid 46161786)
30. Bill A. The role of ciliary body blood flow and ultrafiltration in aqueous humor formation. Exp Eye Res 1973;16:287-298
31. Ghergel D, Hosking SL, Orgul S. Autonomic nervous system, circadian rhythms, and primary open-angle glaucoma. Surv Ophthalmol 2004;49:491-508. (Pubitemid 39504764)
32. Watkins RW, Baum T, Cedeno K, et al. Topical ocular hypotensive effects of the novel angiotensin converting enzyme inhibitor SCH 33861 in conscious rabbits. J Ocul Phamacol 1987;3:295-307. (Pubitemid 18063031)
33. Constad WH, Fiore P, Samson C, et al. Use of an angiotensin converting enzyme inhibitor in ocular hypertension and primary open-angle glaucoma. Am J Ophthalmol 1988;105:674-677 (Pubitemid 18166325)
34. Vogh BP, Godman DR. Effects of inhibition of angiotensin converting enzyme and carbonic anhydrase on fluid production by ciliary process, choroid plexus, and pancreas. J Ocul Pharmacol 1989;5:303-311
35. Shah GB, Sharma S, Mehta AA, et al. Oculohypotensive effect of angiotensinconverting enzyme inhibitors in acute and chronic models of glaucoma. J Cardiovasc Pharmacol 2000;36:169-175 (Pubitemid 30659836)
36. Wang RF, Podos SM, Mittag TW, et al. Effect of CS-088, an angiotensin AT1 receptor antagonist, on intraocular pressure in glaucomatous monkey eyes. Exp Eye Res 2005;80:629-632
37. Inoue T, Yokoyoma T, Mori Y, et al. The effect of topical CS-088, an angiotensin AT1 receptor antagonist on intraocular pressure and aqueous humor dynamics in rabbits. Curr Eye Res 2001;23:133-138 (Pubitemid 34499636)
38. Danser AHJ, Derkx FHM, Admiraal PJJ, et al. Angiontensin levels in the eye. Invest Ophthalmol Vis Sci 1994;35:1008-1018
39. Sramek SJ, Wallow HL, Tewksbury DA, et al. An ocular renin angiotensin system. Immunohistochemistry of angiotensinogen. Invest Ophthalmol Vis Sci 1994;33:1627-1632
40. Wagner J, Jan Danser AH, Derkx FH, et al. Demonstration of renin mRNA, angiotensinogen mRNA, and angiotensin-convertings enzyme mRNA expression in the human eye: Evidence for an intraocular renin-angiotensin system. Br J Ophthalmol 1996;80:159-163 (Pubitemid 26058551)
41. Savaskan E, Loffler KU, Meier F, et al. Immunohistochemical localization of angiotensin-converting enzyme, angiotensin II, and AT1 receptor in human ocular tissues. Ophthalmic Res 2004;36:312-320 (Pubitemid 40069656)
42. Hvidberg A, Kessing SV, Fernandes A. Effect of changes in PCO2 and body positions on intraocular pressure during general anaesthesia. Acta Ophthalmol (Copenh) 1981;59:465-475 (Pubitemid 11014344)
43. Gupta VK. Is benign cough headache caused by intraocular haemodynamic aberration? Med Hypotheses 2004;62:45-48
44. Leighton DA, Phillips CI. Systemic blood pressure in open angle glaucoma, low tension glaucoma, and the normal eye. Br J Ophthalmol 1972;56:447-453
45. Levene RZ. Low tension glaucoma: a critical review and new material. Surv Ophthalmol 1980;24:621-664
46. Goldberg I, Hollows FC, Kass MA, et al. Systemic factors in patients with lowtension glaucoma. Br J Ophthalmol 1981;65:56-62. (Pubitemid 11168935)
47. Rouhiainen HJ, Teräsvirta ME. Hemodynamic variables in progressive and non-progressive low tension glaucoma. Acta Ophthalmol (Copenh) 1990;68:34-36
48. Kashiwagi K, Hosaka O, Kashiwagi F, et al. Systemic circulatory parameters. Comparison between patients with normal tension glaucoma and normal subjects using ambulatory monitoring. Jpn J Ophthalmol 2001;45:388-396 (Pubitemid 32694683)
49. Wang N, Peng Z, Fan B, et al. Case control study on the risk factors of primary open angle glaucoma in China. Zhonghua Liu Xing Bing Xue Za Zhi 2002;23:293-296
50. Sachsenweger R. Der Einfluß des Bluthochdrucks auf die Prognose des Glaukoms. Klin Monatsbl Augenheilkd 1963;142:625-633
51. Demailly P, Cambien F, Plouin PF, et al. Do patients with low tension glaucoma have particular cardiovascular characteristics? Ophthalmologica 1984;188:65-75.
52. Kaiser HJ, Flammer J, Burckhardt D. Silent myocardial ischemia in glaucoma patients. Ophthalmologica 1993;207:6-7.
53. Hayreh SS, Zimmerman MB, Podhajsky P, et al. Nocturnal arterial hypotension and its role in optic nerve head and ocular ischemic disorders. Am J Ophthalmol 1994;117:603-624 (Pubitemid 24150730)
54. Graham SL, Drance SM, Wijsman K, et al. Ambulatory blood pressure monitoring in glaucoma. The nocturnal dip. Ophthalmology 1995;102:61-69
55. Collignon N, Dewe W, Guillaume S, et al. Ambulatory blood pressure monitoring in glaucoma patients. The nocturnal systolic dip and its relationship with disease progression. Int Ophthalmol 1998;22:19-25.
56. Graham SL, Drance SM. Nocturnal hypotension: role in glaucoma progression. Surv Ophthalmol 1999;43(1 Suppl):10-16S.
57. Kaiser HJ, Flammer J. Systemic hypotension: a risk factor for glaucomatous damage? Ophthalmologica 1991;203:105-108
58. Kaiser HJ, Flammer J, Graf T, et al. Systemic blood pressure in glaucoma patients. Graefes Arch Clin Exp Ophthalmol 1993;231:677-680 (Pubitemid 24026550)
59. Drance SM, Morgan RW, Sweeney VP. Shock-induced optic neuropathy: A cause of nonprogressive glaucoma. N Engl J Med 1973;288:392-395
60. Drance SM, Sweeney VP, Morgan RW, et al. Studies of factors involved in the production of low tension glaucoma. Arch Ophthalmol 1973;89:457-465
61. Drance SM, Wheeler C, Pattullo M. Uniocular open-angle glaucoma. Am J Ophthalmol 1968;65:891-902.
62. Hayreh SS, Podhajsky P, Zimmerman MB. Role of nocturnal arterial hypotension in optic nerve head ischemic disorders. Ophthalmologica 1999;213:76-96. (Pubitemid 29049393)
63. Hayreh SS. The role of age and cardiovascular disease in glaucomatous optic neuropathy. Surv Ophthalmol 1999;43(1 Suppl):27-42S.
64. Hayreh SS. The blood supply of the optic nerve head and the evaluation of it - myth and reality. Prog Retin Eye Res 2001;20:563-593 (Pubitemid 32695342)
65. Hayreh SS. Blood flow in the optic nerve head and factors that may influence it. Prog Retin Eye Res 2001;20:595-624. (Pubitemid 32720393)
66. Detry M, Boschi A, Ellinghaus G, et al. Simultaneous 24-hour monitoring of intraocular pressure and arterial blood pressure in patients with progressive and non-progressive primary open-angle glaucoma. Eur J Ophthalmol 1996;6:273-278 (Pubitemid 26346054)
67. Flammer J, Orgül S, Costa VP, et al. The impact of ocular blood flow in glaucoma. Prog Retin Eye Res 2002;21:359-393 (Pubitemid 34879080)
68. Choi J, Kim KH, Jeong J, et al. Circadian fluctuation of mean ocular perfusion pressure is a consistent risk factor for normal-tension glaucoma. Invest Ophthalmol Vis Sci 2007;48:104-111 (Pubitemid 47251393)
69. Orgül S, Gugleta K, Flammer J. Physiology of perfusion as it relates to the optic nerve head. Surv Ophthalmol 1999;43(1 Suppl):17-26S. (Pubitemid 29328576)
70. Kario K, Matsuo T, Kobayashi H, et al. Nocturnal fall of blood pressure and silent cerbrovascular damage in elderly hypertensive patients. Advanced silent cerebrovascular damage in extreme dippers. Hypertension 1996;27:130-135
71. Halberg F, Cornelissen G, Halberg E. Chronobiology of human blood pressure. In: Halberg F, Cornelissen G, Halberg E, eds. Medtronic continuing medical education seminars. 2nd edn. Minneapolis: Medtronic, 1987:234.
72. Detry M, Boschi A, Ellinghaus G, et al. Simultaneous 24-hour monitoring of intraocular pressure and arterial blood pressure in patients with progressive and non-progressive primary open-angle glaucoma. Eur J Ophthalmol 1996;6:273-278 (Pubitemid 26346054)
73. Collignon N, Dewe W, Guillaume S, et al. Ambulatory blood pressure monitoring in glaucoma patients. The nocturnal systolic dip and its relationship with disease progression. Int Ophthalmol 1998;22:19-25.
74. Tokunaga T, Kashiwagi K, Tsumura T, et al. Association between nocturnal blood pressure reduction and progression of visual field defect in patients with primary open-angle glaucoma or normal-tension glaucoma. Jpn J Ophthalmol 2004;48:380-385 (Pubitemid 39013906)
75. Anderson DR. Glaucoma, capillaries and pericytes: 1. Blood flow regulation. Ophthalmologica 1996;210:257-262
76. Anderson DR. Optic nerve blood flow. In: Drance SM, Anderson DR, eds. Optic nerve in glaucoma. New York: Kugler Publications, 1995:311-331
77. Berne RM, Levy MN. Physiology. 3rd edn. St. Louis: Mosby Year Book, 1993:472, 481-494
78. Guyton AC. Textbook of medical physiology. 7th edn. Philadelphia: W B Saunders, 1986:230-235
79. Haefliger IO, Anderson DR. Blood flow regulation in the optic nerve head. In: Ritch R, Shields MB, Krupin T, eds. The glaucomas, Vol.1. St. Louis, Mosby, 1996:189-197
80. Anderson DR. Introductory comments on blood flow autoregulation in the optic nerve head and vascular risk factors in glaucoma. Surv Ophthalmol 1999;43(1 Suppl):S5-9.
81. Grunwald JE, Riva CE, Stone RA, et al. Retinal autoregulation in open-angle glaucoma. Ophthalmology 1984;91:1690-1694
82. Jonas JB, Nguyen XN, Naumann GO. Parapapillary retinal vessel diameter in normal and glaucoma eyes. I. Morphometric data. Invest Ophthalmol Vis Sci 1989;30:1599-1603
83. Piltz-seymour JR, Grunwald JE, Hariprasad SM, et al. Optic nerve blood flow is diminished in eyes of primary open-angle glaucoma suspects. Am J Ophthalmol 2001;132:63-69
84. Logan JF, Rankin SJ, Jackson AJ. Retinal blood flow measurements and neuroretinal rim damage in glaucoma. Br J Ophthalmol 2004;88:1049-1054
85. Langman M, Lancashire R, Cheng K, et al. Systemic hypertension and glaucoma: mechanisms in common and co-occurrence. Br J Ophthalmol 2005;89:960-963 (Pubitemid 41081402)
86. Mitchell P, Leung H, Wang JJ, et al. Retinal vessel diameter and open-angle glaucoma: the Blue Mountains Eye Study. Ophthalmology 2005;112:245-250 (Pubitemid 40202559)
87. Wong TY, Mitchell P. The eye in hypertension. Lancet 2007;369:425-435
88. Hayreh SS, Jonas JB, Zimmerman MB. Parapapillary chorioretinal atrophy in chronic high-pressure experimental glaucoma in rhesus monkeys. Invest Ophthalmol Vis Sci 1998;39:2296-2303
89. Hayreh SS, Péer J, Zimmerman MB. Morphologic changes in chronic high-pressure experimental glaucoma in rhesus monkeys. J Glaucoma 1999;8:56-71.
90. Hayreh SS, Piegors DJ, Heistad DD. Serotonin induced constriction of ocular arteries in atherosclerotic monkeys: Implications for ischemic disorders of retina and optic nerve head. Arch Ophthalmol 1997;115:220-228 (Pubitemid 27083795)
91. Hayreh SS, Servais GE, Virdi PS, et al. Fundus lesions in malignant hypertension: III. Arterial blood pressure, biochemical, and fundus changes. Ophthalmology 1986;93:45-59.
92. Timio M, Venanzi S, Lolli S, et al. "Non-dipper" hypertensive patients and progressive renal insufficiency: a 3-year longitudinal study. Clin Nephrol 1995;43:382-387
93. Quigley HA, West SK, Rodriguez J, et al. The prevalence of glaucoma in a population-based study of Hispanic subjects: Proyecto VER. Arch Ophthalmol 2001;119:1819-1826 (Pubitemid 33139614)
94. Leske MC, Heijl A, Hyman L, et al. EMGT Group. Predictors of long-term progression in the Early Manifest Glaucoma Trial. Ophthalmology 2007;114:1965-1972
95. Schmetterer L, Garhofer G. How can blood flow be measured? Surv Ophthalmol 2007;52(2 Suppl):134-8S.
96. Bill A, Sperber GO. Control of retinal and choroidal blood flow. Eye 1990;4:319-325 (Pubitemid 20307088)
97. Harris A, Chung HS, Ciulla TA, et al. Progress in measurement of ocular blood flow and relevance to our understanding of glaucoma and age-related macular degeneration. Prog Retin Eye Res 1999;18:669-687 (Pubitemid 29299154)
98. Bergea B, Bodin L, Svedbergh B. Impact of intraocular pressure regulation on visual fields in open-angle glaucoma. Ophthalmology 1999;106:997-1004. (Pubitemid 30191561)
99. Asrani SG, Zeimer R, Wilensky J, et al. Large diurnal fluctuations in IOP are an independent risk factor in glaucoma patients. J Glaucoma 2000;9:134-142 (Pubitemid 32441322)
100. Oliver JE, Hattenhauer MG, Herman D, et al. Blindness and glaucoma: a comparison of patients progressing to blindness from glaucoma with patients maintaining vision. Am J Ophthalmol 2002;133:764-772 (Pubitemid 34580623)